scholarly journals Rare enough ? Cardiac Device‐related pocket Infection due to Mycobacterium fortuitum

2021 ◽  
Author(s):  
Reshma Golamari ◽  
Nitasa Sahu ◽  
Rama Vunnam ◽  
Dhirisha Bhatt ◽  
Rameet Thapa ◽  
...  
Keyword(s):  
Mycobacterium Fortuitum ◽  
Cardiac Device ◽  
Pocket Infection

scholarly journals Mycobacterium peregrinum Pacemaker Pocket Infection: A Case Report and Review of the Literature

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
A. F. Lazo-Vasquez ◽  
J. A. Gonzales-Zamora
Keyword(s):  
Case Report ◽  
Clinical Case ◽  
Implantable Devices ◽  
Mycobacterium Fortuitum ◽  
Review Of The Literature ◽  
Therapeutic Success ◽  
Cardiac Device ◽  
Central Lines ◽  
Cardiac Devices ◽  
Pocket Infection

Mycobacterium peregrinum is a rapidly growing mycobacterium (RGM), subspecies of Mycobacterium fortuitum complex, which can cause infections in the skin, surgical sites, and central lines. It has also been associated with implantable devices such as cardiac devices. Our objective is to present an atypical clinical case of M. peregrinum infection associated with a cardiac device, review the published literature, and highlight the importance of this type of RGM infection to enhance their therapeutic success. Only two other cases have been reported of M. peregrinum infection associated with cardiac devices. Diagnosis and treatment of Mycobacterium peregrinum infection can be challenging, and the literature is scarce. Better understanding and further research should be conducted regarding this infection.

scholarly journals Rare Enough ? Cardiac Device Related Pocket Infection due to Mycobacterium fortuitum

2020 ◽  
Author(s):  
Reshma Golamari ◽  
Nitasa Sahu ◽  
Rama Vunnam ◽  
Ramesh Thapa ◽  
Ravi Patel ◽  
...  
Keyword(s):  
Mycobacterium Fortuitum ◽  
Cardiac Device ◽  
Pocket Infection

scholarly journals Rare Enough ? Cardiac Device Related Pocket Infection due to Mycobacterium fortuitum

2020 ◽  
Author(s):  
Reshma Golamari ◽  
Nitasa Sahu ◽  
Rama Vunnam ◽  
Dhirisha Bhatt ◽  
Rameet Thapa ◽  
...  
Keyword(s):  
Mycobacterium Fortuitum ◽  
Cardiac Device ◽  
Pocket Infection

Severe pacemaker pocket infection during the COVID-19 pandemic, transvenous lead removal

2021 ◽  
Vol 15 (09) ◽  
pp. 1277-1280
Author(s):  
Milos Dusan Babic ◽  
Lazar Angelkov ◽  
Milosav Tomovic ◽  
Mihailo Jovicic ◽  
Darko Boljevic ◽  
...  
Keyword(s):  
Case Report ◽  
Delayed Diagnosis ◽  
Lead Removal ◽  
Pacemaker Lead ◽  
Cardiac Device ◽  
Delayed Treatment ◽  
Pocket Infection ◽  
Endocardial Lead ◽  
Lead Endocarditis

Introduction: The estimated infection rate after permanent endocardial lead implantation is between 1% and 2%. Pacemaker lead endocarditis is treated with total removal of the infected device and proper antibiotics. In this case report, we present a patient with delayed diagnosis and treatment due to the COVID-19 outbreak. Case Report: An 88-year-old, pacemaker dependent woman with diagnosed pacemaker pocket infection was admitted to the University Cardiovascular institute. The patient had a prolonged follow-up time due to the COVID-19 outbreak. She missed her routine checkup and came to her local hospital when the generator had already protruded completely, to the point where she held it in her own hand. Transthoracic echocardiogram showed possible vegetations on the lead. Transesophageal echocardiography was not performed due to the COVID-19 pandemic. On the day after the admission the patient underwent transvenous removal of the pacemaker lead using a 9 French gauge rotational extraction sheathe (Cook Medical). The extracted lead was covered in a thin layer of vegetations. Further follow-ups showed good recovery with no complications. Conclusions: A case showing delayed treatment of pacemaker pocket infection, due to delayed follow-up time during the COVID-19 pandemic. This patient underwent successful transvenous removal of the infected pacemaker lead, along with adequate antibiotic therapy, which has proven to be the most effective method of treating cardiac device-related endocarditis.

scholarly journals Implantable Cardiac Device Infections Prevalence: Diagnostic and Therapeutic Implications

2021 ◽  
Vol 9 (B) ◽  
pp. 909-916
Author(s):  
Hend Yahia ◽  
Abdo Alazab ◽  
Randa Aly ◽  
Sameh Elmaraghi ◽  
Ashraf Andraos
Keyword(s):  
Risk Factors ◽  
Mortality Rate ◽  
Infection Rate ◽  
High Rate ◽  
Cardiac Resynchronization ◽  
Entire System ◽  
Cardiac Device ◽  
Mortality And Morbidity ◽  
Cardiac Resynchronization Therapy Devices ◽  
Pocket Infection

Background:  It has been demonstrated that the use of cardiac implanted electronic devices (CIED) improve mortality and survivability in a variety of patient populations. Nevertheless, CIED related infection is a serious complication characterized by a high rate of mortality and morbidity. Objectives: To evaluate the prevalence of CIED related infections, risk factors, clinical and demographic characteristics, causative organisms, and the management and outcome of patients presented in the Critical Care Department, Cairo University. Methods: A retrospective analysis was conducted in 1871 individuals who had been implanted with a cardiac device with a total number of devices of 1968 and 2270 procedures performed from January 2007 to December 2017. Results: 59 infectious episodes were identified with an estimated incidence of 2.99% of inserted devices and 2.6% of total procedures.  The infection rate was considerably higher in patients with multiple procedures than those who had a single procedure (9.27% vs. 1.18%; P<0.001). The individuals with a dual-chamber implantable cardiac defibrillator (ICD) and cardiac resynchronization therapy devices (CRTD) had the highest infection rate of 6.25% & 6.85%, respectively. The rate of pocket infection (PI) and CIED related endocarditis (CDE) was 1.54% & 1.06% of total devices respectively.  Numerous risk factors have been found; the most significant of those are diabetes mellitus, recurrent procedures, the device's complexity, and the existence of more than one lead. Gram-positive cocci were the most isolated organisms in all positive cultures (69.23%). Echocardiography revealed lead vegetations and valvular vegetations in 22 patients and 2 patients respectively.  In 53 cases (89.83%), the devices were removed; in 41 cases, the entire system was removed; and in 12 cases, only the generator was removed. The mortality rate was found to be 10.17%, having a considerably higher prevalence in CDE individuals than in pocket infection individuals (20.83% vs. 2.86%; P=0.025). Conclusion: In our center, while the rate of CIED implantation continues to increase, the incidence rate of CIED-related infection continues to decline. Until now, the infection burden associated with secondary intervention is still significantly high.  The management strategy of selection is to eliminate the entire system for patients presented with infection especially those with CDE. However, the mortality rate is still high.

scholarly journals Cardiac Device Infections due toMycobacterium fortuitum

2005 ◽  
Vol 16 (3) ◽  
pp. 183-185 ◽  
Author(s):  
Marion Hemmersbach-miller ◽  
Miguel A Cardenes-Santana ◽  
Alicia Conde-Martel ◽  
José A Bolanos-Guerra ◽  
María I Campos-Herrero
Keyword(s):  
Clinical Management ◽  
Signs And Symptoms ◽  
Term Therapy ◽  
Mycobacterium Fortuitum ◽  
Cardiac Device ◽  
Slow Progression ◽  
Device Infection ◽  
Cardiac Device Infection ◽  
Long Term Therapy

Two cases of cardiac device infection due toMycobacterium fortuitumare reported along with a discussion of their clinical management. Long-term therapy and removal of the infected device is needed. The slow progression and absence of systemic signs and symptoms suggest a low pathogenicity ofM fortuitum.

scholarly journals 1178. Cardiac Device Infection: Do We Follow the Guidelines?

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S422-S422
Author(s):  
Sandhya Nagarakanti ◽  
Eliahu Bishburg ◽  
Anita Bapat
Keyword(s):  
Electronic Device ◽  
Tertiary Care ◽  
Extraction Procedure ◽  
Heart Association ◽  
Care Hospital ◽  
Cardiac Device ◽  
Device Infection ◽  
Microbiological Criteria ◽  
Pocket Infection ◽  
Work Up

Abstract Background Cardiovascular implantable electronic device (CIED) such as pacemaker (PPM) and automated implantable cardiac defibrillator (AICD) are commonly utilized in clinical practice. Definitions of device infection (DI) and guidelines for the work up and device extraction (DE) have been published by the American Heart Association and the Infectious Disease Society of America. Our objective was to evaluate whether the work up of DI as recommended was followed, and whether the device was extracted according to guidelines. Methods A retrospective review in a 680-bed tertiary care hospital. Adult patients (patients) >18 years. who were diagnosed as having a DI and had the device extracted between 2008 and 2017 were included. Data were collected on demographics, device duration, blood culture (BC), echocardiogram utilization, lead cultures (LC) and device pocket cultures, appropriateness of extraction as per guidelines. Results Ninety-five patients were included. Mean age 68 years (range 23–90). 67 (70%) were male. Devices included: AICD in 75 (79%), PPM in 20(21%). CIED was present <1 year prior to infection in 24(24%). Compliance with guidelines recommendation to draw blood cultures, obtain an echocardiogram and send lead cultures and device pocket cultures were seen in 100%, 90.5% and 49.4% and 67.7%, respectively. Criteria for extraction was met in 65/95 (69%); reason for extraction was a pocket infection in 16/65(24.6%), bacteremia in 49/65 (75%), infective endocarditis in 38/65(58%). Thirty (31.5%) had device extracted without meeting guidelines recommendation, in 17 a diagnosis of pocket infection but without microbiological criteria or clinical diagnosis. In 9 patients lead vegetations were seen but no cultures to support extraction. Mortality was seen in 4 patients, one during the extraction procedure. Conclusion In our institution, 1/3 of the patients diagnosed with DI had no indication for DE. Guidelines recommendation for CIED extraction should be followed as extraction could be associated with significant complications. In this study, overall compliance with guidelines work up recommendations were not consistently followed, especially LC and device pocket cultures. Disclosures All authors: No reported disclosures.

Mycobacterium fortuitum pacemaker infection: A case report

2021 ◽  
Author(s):  
Yahya Shabi ◽  
David Haldane ◽  
Paul Bonnar
Keyword(s):  
Case Report ◽  
Infective Endocarditis ◽  
Bloodstream Infections ◽  
Mycobacterium Fortuitum ◽  
Pacemaker Lead ◽  
Cardiac Device ◽  
Pacemaker Infection ◽  
Lead Infection ◽  
Soil And Water

Mycobacterium fortuitum is a rapidly growing mycobacterium, ubiquitous in soil and water, but it is an uncommon cause of infections in immunocompetent hosts. Cardiac device infections and bloodstream infections due to non-tuberculous mycobacteria are rare. We present the case of an 85-year-old patient with infective endocarditis and pacemaker lead infection secondary to M. fortuitum.

Automatic Remote Monitoring of Implantable Cardiac Devices in Clinical Practice – The Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) Trial

2010 ◽  
Vol 6 (3) ◽  
pp. 87
Author(s):  
Niraj Varma ◽  
Keyword(s):  
Clinical Practice ◽  
Remote Monitoring ◽  
Home Monitoring ◽  
Implantable Devices ◽  
Cardiac Device ◽  
Cardiac Devices ◽  
Enhance Patient Safety ◽  
Implantable Cardiac Devices ◽  
Post Implantation

The use of implantable electronic cardiac devices is increasing. Post-implantation follow-up is important for monitoring both device function and patient condition; however, clinical practice is inconsistent. For example, implantable cardioverter–defibrillator follow-up schedules vary from every three months to yearly according to facility and physician preference and the availability of resources. Importantly, no surveillance occurs between follow-up visits. By contrast, implantable devices with automatic remote monitoring capability provide a means for performing constant surveillance, with the ability to identify salient problems rapidly. The Lumos-T Reduces Routine Office Device Follow-up Study (TRUST) demonstrated that remote home monitoring reduced clinic burden and allowed early detection of patient and/or system problems, enabling efficient monitoring and an opportunity to enhance patient safety. The results of the trial have significant implications for the management of patients receiving all forms of implantable electronic cardiac device.

Sign in / Sign up

Export Citation Format

Share Document